|
Index of reports
> Cases with Neutropenia (123)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 123 Next >>
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Prednisolone side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Prednisolone side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male
Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mercaptopurine
Indication: Crohn's Disease
Azathioprine Sodium
Dosage: 2.5 mg/kg
Indication: Crohn's Disease
Azathioprine Sodium
Start date: 2002-01-01
End date: 2006-09-01
Prednisolone
Indication: Product Used FOR Unknown Indication
Remicade
Indication: Crohn's Disease
End date: 2005-09-29
Azathioprine Sodium
Start date: 2001-06-01
Remicade
Dosage: stopped in february - march (3rd infusion)
End date: 2006-02-01
Other drugs received by patient: Metronidazole; Vitamin B-12
Possible Prednisolone side effects in
Reported by a physician from Korea, Republic of on 2012-08-02
Patient:
Reactions: Pneumonia, Neutropenia, Thrombocytopenia, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 18 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-01-27
End date: 2012-01-30
Prednisolone
Dosage: 58 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-01-27
End date: 2012-01-30
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-01-27
End date: 2012-04-01
Melphalan Hydrochloride
Dosage: 11 mg/m2, unk
Start date: 2012-03-22
End date: 2012-03-25
Possible Prednisolone side effects in 77 year old female
Reported by a physician from Japan on 2012-08-01
Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Blood Urea Increased, Pneumonia, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 5 mg daily
Administration route: Oral
Start date: 2010-04-22
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-04-12
End date: 2011-05-02
Exjade
Dosage: 625 mg, qd
Administration route: Oral
Start date: 2011-05-07
End date: 2011-05-18
Exjade
Dosage: 625 mg, on alternate days
Administration route: Oral
Start date: 2011-05-19
Prednisolone
Dosage: 8 mg, daily
Administration route: Oral
End date: 2009-09-29
Exjade
Dosage: 750 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2009-09-16
End date: 2011-04-03
Prednisolone
Dosage: 7 mg, daily
Administration route: Oral
Start date: 2009-09-30
End date: 2010-02-02
Prednisolone
Dosage: 6 mg, daily
Administration route: Oral
Start date: 2010-02-03
End date: 2010-04-21
Prednisolone
Dosage: 4 mg, unk
Administration route: Oral
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-05-19
End date: 2011-06-01
Other drugs received by patient: Equa; Xalatan; Desferal; Famotidine; Novolin R; RED Blood Cells, Concentrated; Glufast; Novolin R; RED Blood Cells, Concentrated; Alendronate Sodium; Timoptol-XE; Platelets; Novolin R; Amaryl; Novolin R; Azopt; Platelets; Famotidine; Glufast; Clarithromycin; Desferal; Desferal; Mucodyne; Voglibose
Possible Prednisolone side effects in 77 year old female
Reported by a physician from Japan on 2012-08-01
Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Pneumonia, Blood Urea Increased, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 8 mg, daily
Administration route: Oral
End date: 2009-09-29
Exjade
Dosage: 750 mg, qd
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2009-09-16
End date: 2011-04-03
Exjade
Dosage: 625 mg, on alternate days
Administration route: Oral
Start date: 2011-05-19
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Indication: Myelodysplastic Syndrome
Start date: 2011-04-12
End date: 2011-05-02
Exjade
Dosage: 625 mg, qd
Administration route: Oral
Start date: 2011-05-07
End date: 2011-05-18
Prednisolone
Dosage: 7 mg, daily
Administration route: Oral
Start date: 2009-09-30
End date: 2010-02-02
Prednisolone
Dosage: 6 mg, daily
Administration route: Oral
Start date: 2010-02-03
End date: 2010-04-21
Prednisolone
Dosage: 4 mg, unk
Administration route: Oral
Revlimid
Dosage: 5 mg, daily
Administration route: Oral
Start date: 2011-05-19
End date: 2011-06-01
Prednisolone
Dosage: 5 mg daily
Administration route: Oral
Start date: 2010-04-22
Other drugs received by patient: Platelets; Novolin R; Clarithromycin; Xalatan; Desferal; Novolin R; RED Blood Cells, Concentrated; Mucodyne; Famotidine; Famotidine; Azopt; Platelets; Desferal; RED Blood Cells, Concentrated; Alendronate Sodium; Voglibose; Timoptol-XE; Amaryl; Novolin R; Novolin R; Glufast; Glufast; Desferal; Equa
Possible Prednisolone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Prednisolone side effects in
Reported by a physician from Japan on 2012-07-17
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: B-Cell Lymphoma
Rituxan
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-07-16
Patient: male
Reactions: Neutropenia, Lymphocytic Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Prednisolone
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-21
Neulasta
Indication: B-Cell Lymphoma
Start date: 2012-04-20
End date: 2012-04-20
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-16
Other drugs received by patient: Metoclopramide; Morphine Sulphate Drip; Acyclovir; Dipyrone TAB; Pantoprazole
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-07-10
Patient: male
Reactions: Neutropenia, Lymphocytic Infiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-20
End date: 2012-04-20
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Rituxan
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-16
Prednisolone
Dosage: 50 mg, bid
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-21
Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole
Possible Prednisolone side effects in 32 year old male
Reported by a individual with unspecified qualification from Hungary on 2012-07-10
Patient: 32 year old male
Reactions: Hepatic Function Abnormal, Neutropenia
Drug(s) suspected as cause:
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-01
End date: 2011-11-01
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-01
End date: 2011-11-01
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-01
End date: 2011-11-01
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-01
End date: 2011-11-01
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-01
End date: 2011-11-01
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-05
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Rituximab
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in female
Reported by a physician from Germany on 2012-06-28
Patient: female
Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Hypotension, Presyncope, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Mabthera
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Neulasta
Dosage: daily dose 6 mg, 2 x(29 apr 2012+17 may 2012
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Prednisolone
Dosage: frequency 1 times in 2 week for 5 days
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Other drugs received by patient: Enoxaparin Natrium; Aspirin; Ramipril; Tiotropium Bromide; Nebivolol; Torsemide; Pantoprazole; Levothyroxine Sodium; Acyclovir; Simvastatin; Trimethoprim + Sulfamethoxazole
Possible Prednisolone side effects in
Reported by a physician from France on 2012-06-27
Patient:
Reactions: Febrile Neutropenia, Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Dosage: on days 1-5, every 21 days for 6 cycles
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1, every 21 days for 6 cycles
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in 66 year old female
Reported by a physician from Finland on 2012-06-26
Patient: 66 year old female
Reactions: Swelling Face, Nausea, Hepatic Enzyme Increased, Acute Tonsillitis, Sepsis, Neutropenia, Rash Morbilliform, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sulfasalazine
Dosage: unk
Indication: Seronegative Arthritis
Start date: 2012-01-01
End date: 2012-05-01
Prednisolone
Dosage: 10 mg, unk
Indication: Seronegative Arthritis
Start date: 2012-01-01
Other drugs received by patient: Calcium Carbonate; Pantoprazole
Possible Prednisolone side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26
Patient:
Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia
Drug(s) suspected as cause:
Vincristine
Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
Indication: B-Cell Lymphoma
Prednisolone
Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
Administration route: Oral
Indication: B-Cell Lymphoma
Mabthera
Dosage: on day 1 of every cycle
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: given on day 1 of each cycle
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26
Patient: female
Reactions: Syncope, Sepsis, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1493 m
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Neulasta
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Rituximab
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Doxorubicin HCL
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Prednisolone
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Vincristine
Dosage: 3.94 m
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Simvastatin; Levothyroxine; Ramipril; Acyclovir; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Tiotropium Bromide; Trimethoprim + Sulfamethoxazole; Torsemide; Pantoprazole; Nebivolol
Possible Prednisolone side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 54 year old male
Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection
Drug(s) suspected as cause:
Prednisolone
Dosage: 100 mg, day1-14
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Procarbacin
Dosage: 100 mg/m2, day 1-7
Etoposide
Dosage: 200 mg/m2, day1-3
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Bleomycin
Dosage: 10 mg/m2, day 8
Indication: Chemotherapy
Possible Prednisolone side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 37 year old male
Reactions: Neutropenia
Drug(s) suspected as cause:
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Possible Prednisolone side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 49 year old male
Reactions: Neutropenia, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 67 year old male
Reactions: Neutropenia, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Possible Prednisolone side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 30 year old female
Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Peritonitis, Infection
Drug(s) suspected as cause:
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 77 year old male
Reported by a physician from Japan on 2012-06-18
Patient: 77 year old male, weighing 67.0 kg (147.3 pounds)
Reactions: Gastrointestinal Haemorrhage, Pyrexia, Ammonia Decreased, Blood Bilirubin Decreased, Liver Disorder, C-Reactive Protein Increased, Depressed Level of Consciousness, Neutropenia, Blood Pressure Decreased, Melaena, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Indication: Prostate Cancer Recurrent
Start date: 2012-05-22
Docetaxel
Dosage: dose: 70mg/m2/day
Indication: Prostate Cancer Recurrent
Start date: 2012-05-22
End date: 2012-05-22
Possible Prednisolone side effects in
Reported by a individual with unspecified qualification from Austria on 2012-06-18
Patient:
Reactions: Cardiac Failure, Febrile Neutropenia, Cardiotoxicity, Neutropenia
Drug(s) suspected as cause:
Vincristine Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisolone side effects in 59 year old male
Reported by a physician from Finland on 2012-06-15
Patient: 59 year old male, weighing 113.0 kg (248.6 pounds)
Reactions: Pneumonia, Haematuria, Neutropenia, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cabazitaxel
Indication: Prostate Cancer
Start date: 2011-03-16
End date: 2011-03-16
Cabazitaxel
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Start date: 2010-04-22
Other drugs received by patient: Calcichew-D3; Selocomp ZOC; Felodipine; Androcur; Lasix; Ibuprofen; Nexium; Xatral CR; Zoladex
Possible Prednisolone side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Oseltamivir
Dosage: 75 mg, 2x/day
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Ciprofloxacin HCL
Dosage: 60 mg
Voriconazole
Dosage: unk
Indication: Aspergillosis
Teicoplanin
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Meropenem
Dosage: 1 g, 2x/day
Indication: Product Used FOR Unknown Indication
Possible Prednisolone side effects in male
Reported by a physician from Germany on 2012-06-11
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: Rulid; Electrolytes NOS W / Macrogol 3350; Acyclovir; Dipyrone TAB; Metoclopramide; Pantoprazole; MST / 00036302 /; Novalgin / 00169801 /; Paspertin / 00041902 /; Acyclovir
Possible Prednisolone side effects in 37 year old male
Reported by a physician from Germany on 2012-06-11
Patient: 37 year old male
Reactions: Plasmablastic Lymphoma, Post Transplant Lymphoproliferative Disorder, Neutropenia
Drug(s) suspected as cause:
Prednisolone
Dosage: 2.5 milligram;
Indication: Immunosuppressant Drug Therapy
Cyclosporine
Dosage: 100 milligram;
Indication: Immunosuppressant Drug Therapy
Azathioprine
Dosage: 100 milligram;
Indication: Immunosuppressant Drug Therapy
Doxorubicin HCL
Dosage: on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Vincristine
Dosage: on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Prednisolone
Dosage: 100mg, d1-5 of 22d cycle; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Cyclophosphamide
Dosage: on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Other drugs received by patient: Sirolimus
Possible Prednisolone side effects in 67 year old male
Reported by a physician from Germany on 2012-06-11
Patient: 67 year old male
Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Vincristine
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Rituximab
Dosage: part of r-chop chemotherapy; later received with bendamustine
Doxorubicin HCL
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Bendamustine
Rituximab
Prednisolone
Dosage: 5 milligram;
Indication: Immunosuppressant Drug Therapy
Prednisone TAB
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Bendamustine
Indication: Plasmablastic Lymphoma
Bendamustine
Dosage: part of r-chop chemotherapy; later received with bendamustine
Rituximab
Dosage: 2 cycles; followed by r-chop
Indication: Plasmablastic Lymphoma
Cyclosporine
Dosage: 200 milligram;
Indication: Immunosuppressant Drug Therapy
Cyclophosphamide
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Other drugs received by patient: Immune Globulin NOS
Possible Prednisolone side effects in 54 year old male
Reported by a physician from Germany on 2012-06-08
Patient: 54 year old male
Reactions: Plasmablastic Lymphoma, Post Transplant Lymphoproliferative Disorder, Bronchopulmonary Aspergillosis, Cytomegalovirus Chorioretinitis, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 mg/m2, d1, 4, 8, 11 of 22d cycle
Indication: Plasmablastic Lymphoma
Bleomycin Sulfate
Dosage: on d8; part of beacoop esc chemotherapy
Indication: Plasmablastic Lymphoma
Prednisolone
Dosage: 40 mg/m2, d1-14 of 22d cycle; part of beacoop esc chemotherapy
Indication: Plasmablastic Lymphoma
Dexamethasone
Dosage: 20mg, d1, 2, 4, 5, 8, 9, 11, 12 of 22d cycle
Indication: Plasmablastic Lymphoma
Sirolimus
Dosage: 1.5 milligram;
Indication: Immunosuppressant Drug Therapy
Procarbazine Hydrochloride
Dosage: 100 mg/m2, d1-7 of 22d cycle; part of beacoop esc chemotherapy
Indication: Plasmablastic Lymphoma
Etoposide
Dosage: 200 mg/m2, d1-3 of 22d cycle; part of beacoop esc chemotherapy
Indication: Plasmablastic Lymphoma
Cyclosporine
Dosage: 45 milligram;
Indication: Immunosuppressant Drug Therapy
Cyclophosphamide
Dosage: on d1; part of beacoop esc chemotherapy
Indication: Plasmablastic Lymphoma
Prednisolone
Dosage: 5 milligram;
Indication: Immunosuppressant Drug Therapy
Page 1 Next >>
|
